InvestorsHub Logo
Followers 172
Posts 17650
Boards Moderated 0
Alias Born 03/02/2012

Re: ClayTrader post# 1989666

Tuesday, 08/20/2019 12:20:09 AM

Tuesday, August 20, 2019 12:20:09 AM

Post# of 2338210
IGEX .0016 biopharma ready to run! MAJOR NEWS COMING as per CEO!!!

https://twitter.com/HuLogix


This is going to get very interesting...



http://www.hulogix.com/


TWITTER on fire with expectations...





https://www.grandviewresearch.com/industry-analysis/pet-care-market

https://www.1millioncups.com/tampa/presentations/hulogix-inc-25424


Veterniary care is $17B industry...

https://www.veterinarypracticenews.com/pet-industry-hits-close-to-70b-in-spending-for-2017/


Just read the filings and the Tweets. IGEX could be worth dollars rather than pennies if Hulogix brings their PATENTED drugs to Market!!!

Currently an agreement is in place with a promising Florida based company focused on companion animal treatments. Americans spent over $72 Billion on their pets in 2018. Management believes accessing this market through this Florida based asset will return significant value to the company and its shareholders.


https://www.otcmarkets.com/stock/IGEX/news/story?e&id=1390508

This deal is LEGIT! 8K Filing on June 26th!

https://www.otcmarkets.com/filing/html?id=13507459&guid=KfJxUK3JS4idrth

READ Exhibit 17.1. MERGER with bonified pet Pharma!

http://archive.fast-edgar.com//20190625/AO2ZR22CD222R2Z2222V22DFUHRUZ22272B2/



FOUR Patents
that have potential to be licensed or put into production.

https://www.vetvine.com/profile/5125/james-hughes

General sm­all animal­ internal ­medicine a­nd surgery­ with spec­ial intere­st in onco­logy/immun­ology; hol­d 4 patent­s on medic­al pharmac­euticals; ­CEO HuLogi­x, a small­ biogen st­art-up, de­veloping e­pigenetic ­therapy mo­dalities f­or feline ­asthma and­ canine ly­mphoma.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149391203



"Veteria" is Dr. Hughe's business. He is legit, and then some!

https://www.yelp.com/biz/vetria-pet-wellness-and-surgical-center-tampa

Here's Dr. Hughes! He loves ANIMALS!!!

http://www.vetriapetclinic.com/our-staff.html

Vetria has served the Tampa community for over 30 years, treating small animals as well as exotics. Dr. Hughes can treat your pet from wellness & vaccinations to major/minor surgeries to stem cell therapy. We are you neighborhood vet servicing all your veterinary needs at neighborhood prices.




History

Established in 1954.
Vetria Pet Wellness & Surgical Center has been providing quality veterinary care in the Tampa Bay Area since 1954.
Meet the Business Owner

Jim H.
Business Owne
r

Dr. Jim Hughes has practiced in the Tampa Bay community for over 30 years, taking care of small animals and exotics. We are your neighborhood clinic, treating pets requiring anything from Orthopedic surgeries to stem cell therapy, from well visits with vaccines to weight loss and acupuncture. You name it, we are here for you, and your family. Dr. Amin is the new addition to our family, practicing for over 2 years, Dr. A loves treating new patients, learning new techniques, as well as experiencing the excitement that comes with small animal care. Come meet our Veterinarians and join the family.


Email From DR. JAMES HUGHES! MUST SEE!!

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149534956

Chris:

Thank you for your interest. I think it's only appropriate to share my CV and I am very excited to talk about epigenetic medicine. If you are not familiar with epigenetics, it is the area of molecular and cellular biology that regulates the expression of genes. Very little of what we are is under the direct control of our genes, but rather, how and when and to what degree our genes are expressed. In fact, of the more than 7000 human diseases that are linked to our genome, only 6 diseases are due to specific DNA mutations in the structural component of the operon (the part of the gene that produces the altered protein that causes the disease). "Lifestyle risk diseases" as defined by the CDC, like obesity, Diabetes II; asthma, addiction, ocular disease, etc are the result of environmentally directed changes to other areas of the operon, particularly promoter sequences upstream from the structural gene that regulate expression of the gene. The mechanism of change is an alteration in the tertiary structure of the promoter sequence, and not an actual alteration in the DNA sequence. Thus epigenetic mechanisms help an organism with a static DNA complement (genome) to adapt to changes in their environment. To get back to disease mechanisms, the problem is that our genome is not compatible with the environment that we have created. Hulogix has dedicated itself to correcting aberrant genomic expression predisposing individuals to disease by identifying and correcting key epigenetic elements.

Our flagship product has completed safety and efficacy trials, an NADA has been submitted and Phase II clinical trials are underway. We have two products that have had provisional patents and one additional product for which a non-provisional patent is pending. That is as much as I feel comfortable sharing at this time. I will forward your request to our board, and provide more information, including my personal CV upon their discretion.


HuLogix Logomini

"We have created an environment in which we are no longer able to thrive"

J. Ulrick Hughes, DVM, MS

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.